Treatment

Recent phase 2 studies indicate that psilocybin-assisted therapy has potential benefits for various neuropsychiatric conditions, including major depressive disorder (MDD). This study explored whether improvements in psychological flexibility...
CURATED BY: Marissa R. DiMambro,
DNP, PMHNP-BC

FDA Approves Rejoyn: First Prescription App for Major Depressive Disorder

The FDA has approved Rejoyn, the first prescription app for major depressive disorder (MDD). Targeted at adults aged 22 and...
CURATED BY:
Delaney Fragale,
PA-C, Psych-CAQ

Review Enhances Youth Depression Care, Highlights Psychotherapy and SSRIs, Urges Further Research

This clinical practice guideline aims to enhance care for children and adolescents with major depressive disorder and persistent depressive disorder...
CURATED BY:
Laura G. Leahy,
DrNP, APRN, PMH-CNS/FNP, CARN-AP, FAANP, FAAN

Report Finds Flaws in STAR*D Study, Suggests Lower Antidepressant Success Rate

A reanalysis in BMJ challenged the original findings of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study by the...
CURATED BY:
Delaney Fragale,
PA-C, Psych-CAQ

Review Shows Electroconvulsive Therapy’s Promise in Treating Major Depressive Disorder and Various Disorders

Researchers of a review focused on electroconvulsive therapy’s (ECT) efficacy, outcomes, safety, and relapse rates, emphasizing its application in various...
CURATED BY:
Delaney Fragale,
PA-C, Psych-CAQ

Stepped Care Internet-Based Cognitive Behavioral Therapy for Depression

Researchers examined the effectiveness of a stepped care internet-based cognitive behavioral therapy (i-CBT) model for depression, characterized by the combination...
CURATED BY:
Marissa R. DiMambro,
DNP, PMHNP-BC

Study Reviews Deep Brain Stimulation as Potential Treatment for Refractory Major Depressive Disorder

Deep brain stimulation (DBS) has emerged as a potential treatment for major depressive disorder (MDD), especially for patients who don't...
CURATED BY:
Marissa R. DiMambro,
DNP, PMHNP-BC
Share